Immunology Letters 1991: Vol 29 Index

7 Pages·1991·1.4 MB·English

KEY WORD INDEX
ACDD Corneal grafting
Fey receptor; Cytotoxicity; Immunoglobulin (Isturiz, M. A., Rejection; Immunological aspects (Prendergast, D. G. C., 73)
271) Cyclosporin
Activation Drug monitoring; Pharmacokinetics (Holt, D. W., 99)
T lymphocyte (Kay, J. E., 51) Cyclosporin
AIDS Graft-versus-host disease; Small bowel transplantation (Wood,
HIV; Dendritic cell; Epidermal Langerhans cell; Dinitro- R. F. M., 157)
chlorobenzene (Stricker, R. B., 191) Cyclosporine
Allograft T cell activation; Sensitation in vivo (Chisholm, P. M., 95)
Epidermal transplantation (Fabre, J. W., 161) Cytokine
Allospecific T cell recognition FK-506; Rapamycin; T cell; Immunosuppression; Graft rejec-
Major histocompatibility complex (Lechler, R., 41) tion (Thomson, A. W., 105)
Antibody Cytotoxicity
Renal transplantation; Blood transfusion; Graft enhancement HAL; Serology; Typing; Histocompatibility (Dyer, P. A., 15)
(MacLeod, A. M., 123) Cytotoxicity
Antigen recognition Fcy receptor; ACDD; Immunoglobulin (Isturiz, M. A., 271)
Eisenia foetida; Oligochaeta; Coelomocyte (Bilej, M., 241)
Artificial antigen receptor Decay-accelerating factor (DAF, CD55)
B cell; T-independent antigen (Peacock, J. S., 247) Deposition of complement C3; Membrane cofactor protein;
Non-Hodgkin’s lymphoma (Fukuda, H., 205)
B cell Dendritic cell
T-independent antigen; Artificial antigen receptor (Peacock, AIDS; HIV; Epidermal Langerhans cell; Dinitrochlorobenzene
J. S., 247) (Stricker, R. B., 191)
Blood transfusion Deposition of complement C3
Renal transplantation; Graft enhancement; Antibody Decay-accelerating factor (DAF, CD55); Membrane cofactor
(MacLeod, A. M., 123) protein; Non-Hodgkin’s lymphoma (Fukuda, H., 205)
Blood transfusion effect Diabetes
Organ transplantation; Tolerance (Bradley, J. A., 127) Pancreatic islet transplantation (Gray, D. W. R., 153)
Bone marrow transplantation Dinitrochlorobenzene
Graft failure; Haplomismatched transplant; HLA-identical sib- AIDS; HIV: Dendritic cell; Epidermal Langerhans cell (Strick-
ling transplant (Hows, J. M., 77) er, R. B., 191)
Bone marrow transplantation Drug monitoring
Immunosuppression; Immunomodulation (Barrett, A. J., 81) Cyclosporin; Pharmacokinetics (Holt, D. W., 99)
Bronchoalveolar cells
MHCclass II-positive cells; Lung allograft rejection (Chang, S.- Eisenia foetida
C.;. 265) Oligochaeta; Coelomocyte; Antigen recognition (Bilej, M., 241)
Epidermal Langerhans cell
CD2-negative T cell AIDS; HIV: Dendritic cell; Dinitrochlorobenzene (Stricker,
Staphylococcal enterotoxin; Superantigen; T cell activation R. B., 191)
(Duan, X., 219) Epidermal transplantation
CD4* cell Allograft (Fabre, J. W., 161)
Veto; Tolerance; T helper cell; MHC class II (Tscherning, T., Exoglycosidase
223) Neuraminidase; Cell surface carbohydrate; Secondary anti-
CD4* T cell clone body response; Suppressor T cell (Nakamura, M., 235)
Human peripheral blood; TeRyé (Kyoizumi, S., 197) Expression
Cell surface carbohydrate Major histocompatibility complex; Tumour; HLA (Ruiz-
Neuraminidase; Exoglycosidase; Secondary antibody response; Cabello, F., 181)
Suppressor T cell (Nakamura, M., 235)
Clinical transplantation Fey receptor
Xenograft (Cairns, T. D. H., 167) Cytotoxicity, ACDD; Immunoglobulin (Isturiz, M. A., 271)
Coelomocyte Fine-needle cytology
Eisenia foetida; Oligochaeta; Antigen recognition (Bilej, M., Renal transplantation; Monitoring (Hughes, D. A., 147)
241)
285
FK-506 Immunological aspects
Rapamycin; T cell; Immunosuppression; Cytokine; Graft rejec- Renal transplantation (Propper, D. J., 65)
tion (Thomson, A. W., 105) Immunological aspects
FK-506 Hepatic transplantation (Adams, D., 69)
Flow cytometry; Lymphocyte subpopulation (Chen, M.-F., 255) immunological aspects
Flow cytometry Corneal grafting; Rejection (Prendergast, D. G. C., 73)
FK-506; Lymphocyte subpopulation (Chen, M.-F., 255) Immunomodulation
Bone marrow transplantation; Immunosuppression (Barrett,
Gene expression A. J., 81)
Interleukin 1; Urate crystal; mRNA (Di Giovine, F. S., 211) Immunophenotypic analysis
Graft enhancement Renal transplantation; Leukocyte infiltration (Fuggle, S. V.,
Renal transplantation; Blood transfusion; Antibody 143)
(MacLeod, A. M., 123) Immunosuppression
Graft failure Bone marrow transplantation; Immunomodulation (Barrett,
Bone marrow transplantation; Haplomismatched transplant; A. J., 81)
HLA-identical sibling transplant (Hows, J. M., 77) I pp ession
Graft rejection FK-506; Rapamycin; T cell; Cytokine; Graft rejection (Thom-
FK-506; Rapamycin; T cell; Immunosuppression; Cytokine son, A. W., 105)
(Thomson, A. W., 105) Immunosuppressive therapy
Graft-versus-host disease Renal transplantation; Rejection (Briggs, J. D., 89)
Small bowel transplantation; Cyclosporin (Wood, R. F. M., Interleukin 1
157) Urate crystal; Gene expression; mRNA (Di Giovine, F. S., 211)
HAL Lepidoglyphus destructor allergen
Serology; Cytotoxicity; Typing; Histocompatibility (Dyer, Storage mice; Mite allergy; Monoclonal antibody (Ventas, P.,
PP A;, 15) 229)
Haplomismatched transplant Leukocyte infiltration
Bone marrow transplantation; Graft failure; HLA-identical sib- Renal transplantation; Immunophenotypic analysis (Fuggle,
ling transplant (Hows, J. M., 77) S. V.,143)
Hepatic transplantation Lung allograft rejection
Immunological aspects (Adams, D., 69) ‘Bronchoalveolar cells; MHC class II-positive cells (Chang, S.-
Histocompatibility C., 265)
HAL; Serology; Cytotoxicity; Typing (Dyer, P. A., 15) Lymphocyte
HIV Neuroimmunomodulation; Stress; Muscular exercise; Naltrex-
AIDS; Dendritic cells; Epidermal Langerhans cell; Dinitro- one (Ferry, A., 261)
chlorobenzene (Stricker, R. B., 191) Lymphocyte subpopulation
HLA FK-506; Flow cytometry (Chen, M.-F, 255)
Major histocompatibility complex; Tumour; Expression (Ruiz-
Cabello, F., 181) Major histocompatibility complex
HLA antigen Restriction fragment length polymorphism (Middleton, D., 31)
HLA class I; HLA class II; One-dimensional isoelectric focuss- Major histocompatibility complex
ing; Two-dimensional electrophoresis (Lanchbury, J. S. S., 23) Polymerase chain reaction (Wordsworth, P., 37)
HLA class I Major histocompatibility complex
HLA antigen; HLA class II; One-dimensional isoelectric Allospecific T cell recognition (Lechler, R., 41)
focussing; Two-dimensional electrophoresis (Lanchbury, Major histocompatibility complex
5. 8. S.,.23) Tumour; HLA; Expression (Ruiz-Cabello, F., 181)
HLA class Il Membrane cofactor protein (MCP,C CD46)
HLA antigen; HLA class I; One-dimensional isoelectric focuss- Deposition of complement C3; Decay-accelerating factor
ing; Two-dimensional electrophoresis (Lanchbury, J. S. S., 23) (DAF, CD55; Non-Hodgkin’s lymphoma (Fukuda, H., 205)
HLA matching MHC antigen expression
Transplantation (Bradley, B. A., 55) Transplantation (Fabre, J. W., 3)
HLA-identical sibling transplant MHC class Il
Bone marrow transplantation; Graft failure; Haplomismatched Veto; Tolerance; CD4* cell; T helper cell (Tscherning, T., 223)
transplant (Hows, J. M., 77) MHC class II-positive cells
Human peripheral blood Bronchoalveolar cells; Lung allograft rejection (Chang, S.-C.,
CD4+ T cell clone; TcRyé (Kyoizumi, S., 197) 265)
Minor histocompatibility antigen
Immunoglobulin Transplantation (Simpson, E., 9)
Fey receptor; Cytotoxicity; ACDD (Isturiz, M. A., 271)
286
Mite allergy Rejection
Lepidoglyphus destructor allergen; Storage mite; Monoclonal Renal transplantation; Immunosuppressive therapy (Briggs,
antibody (Ventas, P., 229) J. D., 89)
Monitoring Rejection
Renal transplantation; Rejection (Salaman, J. R., 139) Renal transplantation; Monitoring (Salaman, J. R., 139)
Monitoring Renal transplantation
Renal transplantation; Fine-needle cytology (Hughes, D. A., Sensitised patient; Negative cross-match (Claas, F. H. J., 61)
147) Renal transplantation
Monoclonal antibody Immunological aspects (Propper, D. J., 65)
Transplantation; Polyclonal antibody (Taylor, R. M. R., 113) Renal transplantation
Monoclonal antibody Immunosuppressive therapy; Rejection (Briggs, J. D., 89)
Therapy; Tolerance; Transplantation (Cobbold, S. P., 117) Renal transplantation
Monoclonal antibody Blood transfusion; Graft enhancement; Antibody (MacLeod,
Lepidoglyphus destructor allergen; Storage mite; Mite allergy A. M., 123)
(Ventas, P., 229) Renal transplantation
Muscular exercise Rejection; Monitoring (Salaman, J. R., 139)
Neuroimmunomodulation; Stress; Lymphocyte; Naltrexone Renal transplantation
(Ferry, A., 261) Leukocyte infiltration; Immunophenotypic analysis (Fuggle,
S. V., 143)
Naltrexone Renal transplantation
Neuroimmunomodulation; Stress; Muscular exercise; Lympho- Monitoring; Fine-needle cytology (Hughes, D. A., 147)
cyte (Ferry, A., 261) Restriction fragment length polymorphism
Negative cross-match Major histocompatibility complex (Middleton, D., 31)
Renal transplantation; Sensitised patient (Claas, F. H. J., 61) mRNA
Neuraminidase Interleukin 1; Urate crystal; Gene expression (Di Giovine, F. S.,
Exoglycosidase; Cell surface carbohydrate; Secondary anti- 211)
body response; Suppressor T cell (Nakamura, M., 235)
Neuroi dulation Secondary antibody response
Stress; Muscular exercise; Lymphocyte; Naltrexone (Ferry, A., Neuraminidase; Exoglycosidase; Cell surface carbohydrate;
261) Suppressor T cell (Nakamura, M., 235)
Non-Hodgkin’s lymphoma Sensitation in vivo
Deposition of complement C3; Decay-accelerating factor Cyclosporine; T cell activation (Chisholm, P. M., 95)
(DAF, CD55); Membrane cofactor protein (MCP,C CD46) Sensitised patient
(Fukuda, H., 205) Renal transplantation; Negative cross-match (Claas, F. H. J.,
61)
Oligochaeta Serology
Eisenia foetida; Coelomocyte; Antigen recognition (Bilej, M., HAL; Cytotoxicity; Typing; Histocompatibility (Dyer, P. A.,
241) 15)
One-dimensional isoelectric focussing Small bowel transplantation
HLA antigen; HLA class 1; HLA class II; Two-dimensional Graft-versus-host disease; Cyclosporin (Wood, R. F. M., 157)
electrophoresis (Lanchbury, J. S. S., 23) Staphylococcal enterotoxin
Organ transplantation CD2-negative T cell; Superantigen; T cell activation (Duan, X.,
Tolerance; Blood transfusion effect (Bradley, J. A., 127) 219)
Storage mite
Pancreatic islet transplantation Lepidoglyphus destructor allergen; Mite allergy; Monoclonal
Diabetes (Gray, D. W. R., 153) antibody (Ventas, P., 229)
Pharmacokinetics Stress
Cyclosporin; Drug monitoring (Holt, D. W., 99) Neuroimmunomodulation; Muscular exercise; Lymphocyte;
Polyclonal antibody Naltrexone (Ferry, A., 261)
Transplantation; Monoclonal antibody (Taylor, R. M. R., 113) Superantigen
Polymerase chain reaction CD2-negative T cell; Staphylococcal enterotoxin; 1 ell activa-
Major histocompatibility complex (Wordsworth, P., 37) tion (Duan, X., 219)
Suppressor T cell
Rapamycin Neuraminidase; Exoglycosidase; Cell surface carbohydrate;
FK-506; T cell; Immunosuppression; Cytokine; Graft rejection Secondary antibody response (Nakamura, M., 235)
(Thomson, A. W., 105)
Rejection T cell
Corneal grafting; Immunological aspects (Prendergast, FK-506; Rapamycin; Immunosuppression; Cytokine; Graft re-
D: G. C., 73) jection (Thomson, A. W., 105)
T cell activation Transplantation
Cyclosporine; Sensitation in vivo (Chisholm, P. M., 95) Minor histocompatibility antigen (Simpson, E., 9)
T cell activation Transplantation
CD2-negative T cell; Staphylococcal enterotoxin; Superantigen HLA matching (Bradley, B. A., 55)
(Duan, X., 219) Transplantation
T helper cell Monoclonal antibody; Polyclonal antibody (Taylor, R. M. R.,
Veto; Tolerance; CD4+ cell; MHC class II (Tscherning, T., 223) 113)
T lymphocyte Transplantation
Activation (Kay, J. E., 51) Monoclonal antibody; Therapy; Tolerance (Cobbold, S. P., 117)
T-independent antigen Transplantation
B cell; Artificial antigen receptor (Peacock, J. S., 247) Tolerance (Wood, K. J., 133)
TeRyd Tumour
Human peripheral blood; CD4+ T cell clone (Kyoizumi, S., Major histocompatibility complex. HLA; Expression (Ruiz-
197) Cabello, F., 181)
Therapy Two-dimensional electrophoresis
Monoclonal antibody; Tolerance; Transplantation (Cobbold, HLA antigen; HLA class I; HLA class II; One-dimensional
S. P., 117) isoelectric focussing (Lanchbury, J. S. S., 23)
Tolerance Typing
Monoclonal antibody; Therapy; Transplantation (Cobbold, HAL; Serology; Cytotoxicity; Histocompatibility (Dyer, P. A.,
SP, 117) 15)
Tolerance
Organ transplantation; Blood transfusion effect (Bradley, J. A., Urate crystal
127) Interleukin 1; Gene expression; mRNA (Di Giovine, F. S., 211)
Tolerance
Transplantation (Wood, K. J., 133) Veto
Tolerance Tolerance; CD4+ cell; T helper cell; MHC class II (Tscherning,
Veto; CD4* cell; T helper cell; MHC class II (Tscherning, T., T.,. 223)
223)
Transplantation Xenograft
MHC antigen expression (Fabre, J. W., 3) Clinical transplantation (Cairns, T. D. H., 167)
AUTHOR INDEX
Abrams, D. I., see Stricker, R. B., 191 Duan, X. and Kabelitz, D., Stimulation of CD2-negative T cells
Adams, D., Immunological aspects of clinical liver transplanta- by staphylococcal enterotoxin superantigens, 219
tion, 69 Duff, G. W., see Di Giovine, F. S., 211
Akiama, M., see Kyoizumi, S., 197 Dyer, P. A. and Martin, S., Techniques used to define human
Amiridis, I., see Ferry, A., 261 MHC antigens: serology, 15
Austyn, J. M., Antigen presentation and the passenger leukocyte
(Abstract), 171 Easty, D. L., see Prendergast, D. G. C., 73
Elswood, B. F., see Stricker, R. B., 191
Barisas, B. G., see Peacock, J. S., 247
Barrett, A. J., Immunosuppressive therapy in bone marrow trans- Fabre, J. W., Epidermal allografts, 161
plantation, 81 Fabre, J. W., Regulation of MHC expression, 3
Batchelor, R., see Lechler, R., 41 Fashola, T. O. A., see Holt, D. W., 99
Bilej, M., Rossmann, P., VandenDriessche, T., Scheerlinck, J.-P., Ferry, A., Weill, B., Amiridis, I., Laziry, F. and Rieu, M., Splenic
De Baetselier, P., Tuckova, L., Vé tviéka, V. and Rejnek, J., De- immunomodulation with swimming-induced stress in rats, 261
tection of antigen in the coelomocytes of the earthworm, Eise- Franco, R., New possibilities in the therapy of immunodeficiency
nia foetida (Annelida), 241 diseases (Letter to the Editor), 277
Binns, R., see Cairns, T. D. H., 167 Fuggle, S. V., Immunophenotypic analysis of leukocyte infiltra-
Bradley, B. A., The role of HLA matching in transplantation, 55 tion in the renal transplant, 143
Bradley, J. A., The blood transfusion effect: experimental Fukuda, H., Seya, T., Hara, T., Matsumoto, M., Kinoshita, T. and
aspects, 127 Masaoka, T., Deficiency of complement decay-accelerating fac-
Bradley, J. M., Effector mechanisms in allograft rejection, 172 tor (DAF, CD55) in non-Hodgkin’s lymphoma, 205
Briggs, J. D., A critical review of immunosuppressive therapy, 89
Butcher, G., Immunogenetics of transplantation, 172 Garrido, F., see Ruiz-Cabello, F., 181
Geffner, J. R., see Isturiz, M. A., 271
Cairns, T. D. H., Taube, D. H., Stevens, N., Binns, R. and Welsh, Gray, D. W. R., Pancreatic islet transplantation: future prospects,
K. I., Xenografts — future prospects for clinical transplanta- 153
tion, 167
Carosella, E. D. and Pascal, N., TCD4*+ —B lymphocyte adhe- Hara, T., see Fukuda, H., 205
sion is inhibited by human IgG and Fcy fragments (Letter to the Hasegawa, T., see Nakamura, M., 235
Editor), 281 Hirai, Y., see Kyoizumi, S., 197
Carreira, J., see Ventas, P., 229 Holt, D. W., Fashola, T. O. A. and Johnston, A., Monitoring cy-
Catto, G. R. D., see Propper, D. J., 65 closporin: is it still important?, 99
Chang, S.-C., Hsu, H.-K. and Lin, C.-Y., Usefulness of bron- Hows, J. M., Mechanisms of graft failure after human marrow
choalveolar cell profile in early detection of canine lung al- transplantation: a review, 77
lograft rejection, 265 Hsu, H.-K., see Chang, S.-C., 265
Chen, M.-F., Suzuki, H., Maruyama, M. and Yano, S., The in- Hughes, D. A., Fine-needle cytology in the monitoring of human
fluence of FK-506 on the thymus and spleen in normal C3H/He renal allograft progress, 147
mice: flow cytometric analysis of lymphocyte subpopulations,
255 Ichihara, M., see Nakamura, M., 235
Chisholm, P. M., In vivo versus in vitro activity of cyclosporine, Ingham Clark, C. L., see Wood, R. F. M., 157
95 Isobe, K., see Nakamura, M., 235
Claas, F. H. J., Negative cross-match selection of HLA-DR com- Isturiz, M. A., Geffner, J. R. and Pizzolato, M. A., Two different
patible kidneys for highly sensitised patients, 61 Fey receptor-dependent cytotoxic mechanisms triggered by
Claesson, M. H., see Tscherning, T., 223 monoclonal immunoglobulins, 271
Cobbold, S. P., Monoclonal antibody therapy for the induction Iwamoto, T., see Nakamura, M., 235
of transplantation tolerance, 117
Jamshedur Rahman, S. M., see Nakamura, M., 235
Dallman, M. J., Antibodies to T cell activation antigens, 173 Johnston, A., see Holt, D. W., 99
Dallman, M. J., Cytokines and allograft rejection, 174
De Baetselier, P., see Bilej, M., 241 Kabelitz, D., see Duan, X., 219
Di Giovine, F. S., Symons, J. A. and Duff, G. W., Kinetics of IL1 Kay, J. E., Mechanisms of T lymphocyte activation, 51
beta mRNA and protein accumulation in human mononuclear Kinoshita, T., see Fukuda, H., 205
cells, 221
Klein, E., see Ruiz-Cabello, F., 181 Scheerlinck, J.-P., see Bilej, M., 241
Kusunoki, Y., see Kyoizumi, S., 197 Seya, T., see Fukuda, H., 205
Kyoizumi, S., Akiama, M., Hirai, Y. and Kusunoki, Y., Isolation Sharrock, C., T cell receptor structure and function, 176
and characterization of human peripheral blood CD4* T cell Shenton, B., The monitoring of soluble interleukin 2 receptor lev-
clones expressing 6 T cell receptors, 197 els, 177
Simpson, E., Minor histocompatibility antigens, 9
Lanchbury, J. S. S., Techniques used to define human MHC anti- Stevens, N., see Cairns, T. D. H., 167
gens: monoclonals, class I and class II biochemistry, 23 Stricker, R. B., Elswood, B. F. and Abrams, D. I., Dendritic cells
Laziry, F., see Ferry, A., 261 and dinitrochlorobenzene (DNCB): a new treatment approach
Lechler, R., Batchelor, R. and Lombardi, G., The relationship be- to AIDS, 191
tween MHC restricted and allospecific T cell recognition, 41 Suzuki, H., see Chen, M.-F., 255
Lin, C.-Y., see Chang, S.-C., 265 Symons, J. A., see Di Giovine, F. S., 211
Lombardi, G., see Lechler, R., 41
Taube, D. H., see Cairns, T. D. H., 167
MacLeod, A., Thomson, A. and Wood, K., Advances in Trans- Taylor, R. M. R., Monoclonal and polyclonal antibodies: clinical
plantation Immunology (Editorial), 1 aspects, 113
MacLeod, A. M., The blood transfusion effect: clinical aspects, Thomson, A., see MacLeod, A., 1
123 Thomson, A. W., The immunosuppressive macrolides FK-506
Martin, S., see Dyer, P. A., 15 and rapamycin, 105
Maruyama, M., see Chen, M.-F., 255 Trowsdale, J., Molecular organisation of the MHC and structure
Masaoka, T., see Fukuda, H., 205 of MHC molecules, 178
Matsumoto, M., see Fukuda, H., 205 Tscherning, T. and Claesson, M. H., Veto-like down-regulation of
Middleton, D., Techniques to define human MHC antigens: re- T helper cell reactivity in vivo by injection of semi-allogeneic
striction fragment length polymorphisms, 31 spleen cells, 223
Mowat, A. Mcl., Graft-versus-host disease, 176 Tuéckova, L., see Bilej, M., 241
Nakamura, M., Yoshida, T., Isobe, K., Iwamoto, T., Jamshedur VandenDriessche, T., see Bilej, M., 241
Rahman, S. M., Zhang, Y. H., Hasegawa, T., Ichihara, M. and Ventas, P., Carreira, J. and Polo, F., Identification of IgE-binding
Nakashima, I., Modulation of the secondary antibody response proteins from Lepidoglyphus destructor and production of
of murine lymphocytes to sheep red blood cells in vitro by neu- monoclonal antibodies to a major allergen, 229
roaminidase and exoglycosidases, 235 Vétvitka, V., see Bilej, M., 241
Nakashima, I., see Nakamura, M., 235
Wallwork, J., Immunological aspects of heart-lung transplanta-
Pascal, N., see Carosella, E. D., 281 tion, 178
Peacock, J. S., Zschokke, M. E., Barisas, B. G. and Roess, D. A.., Weill, B., see Ferry, A., 261
Antigen activation of human B lymphocytes bearing artificial Welsh, K. I., see Cairns, T. D. H., 167
antigen receptors, 247 White, D., Mechanisms of action of cyclosporin A, 179
Pizzolato, M. A., see Isturiz, M. A., 271 Wood, K., see MacLeod, A., 1
Polo, F., see Ventas, P., 229 Wood, K. J., Alternative approaches for the induction of trans-
Prendergast, D. G. C. and Easty, D. L., Immunological aspects plantation tolerance, 133
of corneal graft rejection, 73 Wood, R. F. M. and Ingham Clark,C . L., Small bowel transplan-
Propper, D. J. and Catto, G. R. D., Immunological aspects of tation: future prospects, 157
clinical renal transplantation, 65 Wordsworth, P., Techniques used to define human MHC anti-
gens: polymerase chain reaction and oligonucleotide probes, 37
Rejnek, J., see Bilej, M., 241
Rieu, M., see Ferry, A., 261 Yano, S., see Chen, M.-F., 255
Roess, D. A., see Peacock, J. S., 247 Yoshida, T., see Nakamura, M., 235
Rossmann, P., see Bilej, M., 241
Ruiz-Cabello, F., Klein, E. and Garrido, F., MHC antigens on hu- Zhang, Y. H., see Nakamura, M., 235
man tumors, 181 Zschokke, M. E., see Peacock, J. S., 247
Salaman, J. R., Monitoring of rejection in renal transplantation,
139